The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $77.46

Today's change-0.13 -0.17%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $77.46

Today's change-0.13 -0.17%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.

Reversal following new 100-day high

DexCom Inc closed lower Friday, dropping (U.S.)$0.13 or 0.17% to (U.S.)$77.46 after setting a new 100-day high. Over the last five days, shares have gained 6.69%, but are down 5.42% for the last year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $74.66
  • Previous close(U.S.) $77.59
  • High(U.S.) $77.83
  • Low(U.S.) $73.17
  • Bid / Ask(U.S.) $73.48 / (U.S.) $81.47
  • YTD % change-5.42%
  • Volume1,560,524
  • Average volume (10-day)1,043,625
  • Average volume (1-month)936,480
  • Average volume (3-month)866,263
  • 52-week range(U.S.) $47.92 to (U.S.) $103.29
  • Beta0.30
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.79
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX1.69%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue11613110593
Total other revenue--------
Total revenue11613110593
Gross profit75917566
Total cost of revenue41403127
Total operating expense13512914897
Selling / general / administrative62615245
Research & development32296524
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-192-42-4
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-192-43-4
Income after tax-192-43-4
Income tax, total--0----
Net income-192-43-4
Total adjustments to net income--------
Net income before extra. items-192-43-4
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-192-43-4
Inc. avail. to common incl. extra. items-192-43-4
Diluted net income-192-43-4
Dilution adjustment--0----
Diluted weighted average shares82828180
Diluted EPS excluding extraordinary itemsvalue per share-0.230.02-0.53-0.05
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.230.02-0.53-0.05